Providing over 670 products (as of 31 December 2021) to patients worldwide
We create high-quality medicines, and make them accessible to people who need them. We have a broad product range and a growing pipeline of new medicines for treating a wide range of diseases. Therapeutic categories include anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory.
670+
Products on the market
32
Manufacturing plants
3
Distinct businesses
Related news
Hikma launches Fulvestrant Injection
20 September 2022
Hikma launches Bortezomib for Injection
20 September 2022
Last reviewed on 30 May 2022